196 results
8-K
EX-10.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
(subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate
8-K
EX-10.1
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit … upon receipt thereof, copies of all audit reports submitted to the Company by independent auditors in connection with each annual, interim or special
8-K
EX-3.2
mh5nv50
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm